These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6330239)

  • 1. Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients.
    Hayakawa Y; Torigoe S; Shiraki K; Yamanishi K; Takahashi M
    J Infect Dis; 1984 Jun; 149(6):956-63. PubMed ID: 6330239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a live varicella vaccine (Oka strain).
    Takahashi M
    Biken J; 1984 Sep; 27(2-3):31-6. PubMed ID: 6100054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation and laboratory markers of the Oka-strain varicella-zoster virus.
    Takahashi M; Hayakawa Y; Shiraki K; Yamanishi K; Asano Y; Ozaki T
    Postgrad Med J; 1985; 61 Suppl 4():37-46. PubMed ID: 3014476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of varicella-zoster virus DNAs of clinical isolates by endonuclease HpaI.
    Hayakawa Y; Yamamoto T; Yamanishi K; Takahashi M
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1817-29. PubMed ID: 3018125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of oka varicella vaccine strain from wild varicella-zoster virus strains isolated from vaccinees and household contact.
    Shiraki K; Horiuchi K; Asano Y; Yamanishi K; Takahashi M
    J Med Virol; 1991 Feb; 33(2):128-32. PubMed ID: 1675658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis.
    Mori C; Takahara R; Toriyama T; Nagai T; Takahashi M; Yamanishi K
    J Infect Dis; 1998 Jul; 178(1):35-8. PubMed ID: 9652420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka varicella vaccine strain by VZV ORF 6-based PCR and restriction fragment length polymorphism analysis.
    Takayama M; Takayama N
    J Clin Virol; 2004 Feb; 29(2):113-9. PubMed ID: 14747030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restriction fragment differences between the genomes of the Oka varicella vaccine virus and American wild-type varicella-zoster virus.
    Adams SG; Dohner DE; Gelb LD
    J Med Virol; 1989 Sep; 29(1):38-45. PubMed ID: 2573686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
    Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
    J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restriction endonuclease analysis of varicella-zoster vaccine virus and wild-type DNAs.
    Martin JH; Dohner DE; Wellinghoff WJ; Gelb LD
    J Med Virol; 1982; 9(1):69-76. PubMed ID: 6278073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes zoster in three healthy children immunized with varicella vaccine (Oka/Biken); the causative virus differed from vaccine strain on PCR analysis of the IV variable region (R5) and of a PstI-site region.
    Na GY
    Br J Dermatol; 1997 Aug; 137(2):255-8. PubMed ID: 9292076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults.
    Gelb LD; Dohner DE; Gershon AA; Steinberg SP; Waner JL; Takahashi M; Dennehy PH; Brown AE
    J Infect Dis; 1987 Apr; 155(4):633-40. PubMed ID: 3029239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A real-time PCR assay for the detection of varicella-zoster virus DNA and differentiation of vaccine, wild-type and control strains.
    Tipples GA; Safronetz D; Gray M
    J Virol Methods; 2003 Nov; 113(2):113-6. PubMed ID: 14553897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between of the attenuated BR-Oka and the wild type strain of Varicella Zoster Virus (VZV) on the DNA level.
    Lim SM; Song SW; Kim SL; Jang YJ; Kim KH; Kim HJ
    Arch Pharm Res; 2000 Aug; 23(4):418-23. PubMed ID: 10976594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of clinical varicella-zoster strains from India and differentiation from the oka vaccine strain.
    Kaushik KS; Lahiri KK; Chumber SK; Gupta RM; Kumar S; Kapila K; Karade S
    Jpn J Infect Dis; 2008 Jan; 61(1):65-7. PubMed ID: 18219137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worldwide experience with the Oka-strain live varicella vaccine.
    Andre FE
    Postgrad Med J; 1985; 61 Suppl 4():113-20. PubMed ID: 3014468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.
    Sauerbrei A; Rubtcova E; Wutzler P; Schmid DS; Loparev VN
    J Clin Microbiol; 2004 Dec; 42(12):5604-8. PubMed ID: 15583288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombination in tissue culture between varicella-zoster virus strains.
    Dohner DE; Adams SG; Gelb LD
    J Med Virol; 1988 Mar; 24(3):329-41. PubMed ID: 2835429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
    Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
    Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.